PROM1 and head and neck cancer: Recently, a review paper has summarised the potential pro-survival and anti-apoptosis mechanisms of CD133 in cancer stem cells.9 Chen et al.10 demonstrated that CD133 induces EMT, stemness properties, and tumorigenicity by activating the Src signalling pathway in head and neck cancer cells.